Skip to main content

Table 5 Results by disease state for SDC1 SNP (rs1131351) and of the MS case-control population. Corrected P values using the Benjimini-Hochberg (PBH) and Bonferroni (PBon) methods are presented below the uncorrected P value

From: An investigation of genetic polymorphisms in heparan sulfate proteoglycan core proteins and key modification enzymes in an Australian Caucasian multiple sclerosis population

 

SDC 1

rs113151

Polymorphism

Genotypes

 

Alleles

Group

GG (%)

GC (%)

CC (%)

P

(PBH, PBon)

HWE

G (%)

C (%)

P

OR (95% CI)

MS total cases (n= 160)

31 (19.4)

83 (51.9)

46 (28.8)

0.02

(0.08, 0.16)

0.55

145 (45.3)

175 (54.7)

0.004

1.59

PP case (n= 45)

8 (17.8)

24 (53.3)

13 (28.9)

0.11

 

40 (44.4)

50 (55.6)

0.04

1.65

SP case (n= 39)

8 (20.5)

19 (48.7)

12 (30.8)

0.15

 

35 (44.9)

43 (55.1)

0.06

1.62

RR case (n= 76)

15 (19.7)

40 (52.6)

21 (27.6)

0.09

 

70 (46.1)

82 (53.9)

0.03

1.55

Male (n= 31)

7 (22.6)

17 (54.8)

7 (22.6)

0.58

 

31 (50)

31 (50)

0.32

1.32

Female (n= 129)

24 (18.6)

66 (51.2)

39 (30.2)

0.01

 

114 (44.2)

144 (58.8)

0.003

1.67

Total control (n= 145)

46 (31.7)

73 (50.3)

26 (17.9)

–

0.75

165 (56.9)

125 (43.1)

–

 

HapMap CEU (%)

50

31

19

  

65.5

34.5

 Â